Use the Back button in your browser to see the other results of your search or to select another record.
| Prehabilitation and heart failure: main outcomes in the COVID-19 era | 
| Giovannini S, Coraci D, Loreti C, Castelli L, Di Caro F, Fiori M, Imperia LM, Madathil GG, Padua L, Santagada DA, Biscotti L, Bernabei R | 
| European Review for Medical and Pharmacological Sciences 2022;26(11):4131-4139 | 
| clinical trial | 
| 4/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: No. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* | 
| Copyright release for this abstract has not been granted. 
 |